Xylem (NYSE:XYL) Cut to Neutral at JPMorgan Chase & Co.

Xylem (NYSE:XYL) was downgraded by JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research report issued to clients and investors on Wednesday, Briefing.com reports. They presently have a $90.00 price objective on the industrial products company’s stock. JPMorgan Chase & Co.‘s target price would suggest a potential downside of 3.37% from the stock’s current price.

Several other research analysts also recently weighed in on XYL. Weiss Ratings restated a “hold (c)” rating on shares of Xylem in a research note on Wednesday, August 5th. Barclays decreased their price objective on shares of Xylem from $159.00 to $139.00 and set an “overweight” rating for the company in a research note on Tuesday, October 13th. Oppenheimer restated an “outperform” rating and issued a $150.00 price objective (down from $158.00) on shares of Xylem in a research note on Wednesday, October 14th. Wolfe Research initiated coverage on shares of Xylem in a research note on Tuesday, September 15th. They set a “peer perform” rating on the stock. Finally, UBS Group lowered their price target on shares of Xylem from $138.00 to $112.00 and set a “neutral” rating for the company in a research report on Monday, October 5th. Nine analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $136.38.

Xylem Stock Performance

Shares of XYL stock opened at $93.14 on Wednesday. The stock’s 50 day simple moving average is $106.50 and its two-hundred day simple moving average is $118.31. Xylem has a 1 year low of $92.61 and a 1 year high of $154.27.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing the consensus estimate of $1.45 by ($0.01). The company had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.28 billion. Xylem’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.37 earnings per share. As a group, sell-side analysts forecast that Xylem will post 5.65 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. William Mack & Associates Inc. acquired a new position in Xylem during the third quarter worth $25,000. Dunhill Financial LLC bought a new stake in shares of Xylem during the 2nd quarter valued at $30,000. Avalon Trust Co acquired a new stake in shares of Xylem during the 2nd quarter worth approximately $35,000. Orion Capital Management LLC acquired a new position in shares of Xylem during the 2nd quarter worth $35,000. Finally, Aventus Investment Advisors Inc. boosted its stake in shares of Xylem by 66.7% during the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock valued at $35,000 after purchasing an additional 120 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Key Stories Impacting Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Orders increased 10% year over year, suggesting underlying demand remains healthy despite near-term execution and project-timing issues. Adjusted earnings also rose from the prior-year period to $1.44 per share. Xylem Q3 2026 results
• Positive Sentiment: Management’s planned portfolio restructuring and cost actions could improve business focus and profitability over time, while infrastructure and data-center demand remain potential longer-term growth drivers.
• Neutral Sentiment: Management is preparing a portfolio reset and restructuring program. The effort may support future performance, but it could create transition costs and execution risk before benefits emerge. Xylem portfolio reset
• Negative Sentiment: Third-quarter revenue fell 3% year over year to $2.20 billion, below the approximately $2.28 billion consensus estimate. Earnings of $1.44 per share also missed estimates, reflecting weakness in metering and delayed or softer project activity. Xylem Q3 earnings miss
• Negative Sentiment: Xylem lowered its 2026 revenue and EPS outlook and issued weaker fourth-quarter expectations, signaling that customer pullbacks, project timing and metering pressure may persist. This guidance reduction was the main reason for the selloff. Xylem lowers 2026 outlook
• Negative Sentiment: The consensus price target was reduced by 10.52%, reinforcing concerns about weaker near-term earnings and valuation.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.